MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer
- Authors: Knyazev E.N.1, Samatov T.R.1, Fomicheva K.A.2, Nyushko K.M.2, Alekseev B.Y.2, Shkurnikov M.Y.1,2
-
Affiliations:
- BioClinicum Research and Development Center
- National Medical Research Radiology Center
- Issue: Vol 161, No 1 (2016)
- Pages: 112-115
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/237169
- DOI: https://doi.org/10.1007/s10517-016-3358-6
- ID: 237169
Cite item
Abstract
We analyzed microRNA profile in hemolysis-free blood plasma of patients with prostatic cancer. The metastatic form of prostatic cancer was found to be associated with increased levels of hsa-miR-22-3p, hsa-miR-663a, and hsa-miR-4674 in comparison with non-metastatic form. Common candidate target genes of these microRNA include JUNB, KMT2A, and XPO6.
About the authors
E. N. Knyazev
BioClinicum Research and Development Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
T. R. Samatov
BioClinicum Research and Development Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
K. A. Fomicheva
National Medical Research Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
K. M. Nyushko
National Medical Research Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
B. Ya. Alekseev
National Medical Research Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
M. Yu. Shkurnikov
BioClinicum Research and Development Center; National Medical Research Radiology Center
Author for correspondence.
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow; Moscow